Skip to Main Content

Try STAT+ TODAY

genetics

Most Read

First Opinion Eric B. Kmiec

Secrecy: A demon of gene therapy’s past bedevils its future

Health Isabella Cueto

Girl’s case of lupus leads to new understanding of a perplexing disease

Health Andrew Joseph

If Roe is overturned, the ripples could affect IVF and genetic testing of embryos, experts warn

Health Andrew Joseph

What the surprising mutations in the monkeypox virus could indicate about the new outbreak

In the Lab Isabella Cueto

Hundreds of families share a lethal inheritance. This kidney researcher hopes to break the chain

First Opinion Henry T. Greely

Human reproductive cloning: The curious incident of the dog in the night-time

First Opinion Dorothy Pomerantz

23andMe had devastating news about my health. I wish a person had delivered it

First Opinion Allison Chang

Our child received a devastating diagnosis before she was born. We decided to protect her

All Coverage

In the Lab Elizabeth Cooney

New research digs into the genetic drivers of heart failure, with an eye to precision treatments

First Opinion David Reese and Kári Stefánsson

A better understanding of human diversity is needed to equitably advance precision medicine

advertisement

Health Jonathan Wosen

Genomics is racing toward a $100 genome. Are we ready for it?

Biotech Matthew Herper and Megan Molteni

Verve Therapeutics begins human tests of first ‘base editor,’ aiming at heart disease

Biotech Jason Mast

Beyond a CRISPR treatment’s encouraging results, some scientists see a need for more data on risk

Pharmalot Ed Silverman

Pharmalittle: FDA panel endorses Bluebird Bio gene therapy for rare disease; GSK touts RSV vaccine trial results

The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: Biotech’s Catch-22, a $100 genome, & dealing with monkeypox

In the Lab Megan Molteni

Buffalo shooting ignites a debate over the role of genetics researchers in white supremacist ideology

First Opinion Anna C. F. Lewis

Substituting genetic ancestry for race in research? Not so fast

First Opinion Walter G. Johnson and Diana M. Bowman

It’s time for Congress to stop blocking mitochondrial replacement therapy

Health Andrew Joseph

Omicron splinters into fast-spreading lineages, highlighting coronavirus’s evolution

Health Megan Molteni

For patients, seeing the benefits of the new, fully sequenced genome could take years

Exclusive Megan Molteni

New details emerge about a U.S. scientist’s obscured role in the ‘CRISPR babies’ scandal

Biotech Jonathan Wosen

Illumina sues Guardant Health, saying former employees stole trade secrets to launch liquid biopsy firm

Biotech Jonathan Wosen

Armed with heaps of cash and a veteran team, an upstart looks to disrupt DNA sequencing

Health Lauran Neergaard and Carla K. Johnson — Associated Press

First person to receive a pig heart transplant dies after two months

First Opinion Lee D. Cooper

Rediscovering a language of healing that doesn’t require ‘cure’

Biotech Megan Molteni

With new trial data coming, Intellia CEO talks up the future of in vivo gene editing

In the Lab Eric Boodman

This family carried a rare mutation that should have been lethal. What was keeping them alive?

In the Lab Megan Molteni

Drugs based on next-generation gene editing are moving toward the clinic faster than CRISPR 1.0

Matt's Take Matthew Herper

The fall of Eric Lander and the end of science’s ‘big ego’ era

In the Lab Megan Molteni

A scientific pioneer finds herself on the sidelines of the race in xenotransplantation

Biotech Jonathan Wosen

Illumina’s embrace of long-read technology signals a shift in the DNA-sequencing market

Health Megan Molteni

After a flurry of firsts, xenotransplantation is suddenly back in the spotlight

Health Jonathan Wosen

Researchers shatter the speed record for diagnosing rare genetic diseases with DNA sequencing